Australian Centre for the Prevention of Cervical Cancer

Homepage: acpcc.org.au

Alternate names: VCS Foundation, VCS Foundation Ltd, Victorian Cytology Service, Victorian Cytology Service Incorporated, Victorian Cytology Service Limited

ROR: 01dn93131

OpenAlex ID: I4405283309

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

2018 · Marc Arbyn, Sara B Smith, et al. · BMJ · 935

PDF

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

2015 · Mélanie Drolet, Élodie Bénard, et al. · The Lancet Infectious Diseases · 691

PDF

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

2011 · Julia ML Brotherton, Masha Fridman, et al. · The Lancet · 604

The projected timeframe until cervical cancer elimination in Australia: a modelling study

2018 · Michaela T Hall, Kate T Simms, et al. · The Lancet Public Health · 475

PDF

Human Papillomavirus Vaccine Introduction – The First Five Years

2012 · Lauri E. Markowitz, Vivien Tsu, et al. · Vaccine · 375

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?

2018 · Cyra Patel, Julia ML Brotherton, et al. · Eurosurveillance · 370

PDF

Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review

2006 · Elizabeth Davey, Alexandra Barratt, et al. · The Lancet · 317

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

2014 · Sepehr N Tabrizi, Julia M L Brotherton, et al. · The Lancet Infectious Diseases · 308

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

2013 · Dorota M Gertig, Julia ML Brotherton, et al. · BMC Medicine · 282

PDF

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

2012 · S. N. Tabrizi, J. M. L. Brotherton, et al. · The Journal of Infectious Diseases · 269

EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease

2012 · Marc Arbyn, Silvia de Sanjosé, et al. · International Journal of Cancer · 254

PDF

Oestrogenic effects of plant foods in postmenopausal women.

1990 · G Wilcox, M L Wahlqvist, et al. · BMJ · 222

PDF

Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia

2014 · E. Crowe, N. Pandeya, et al. · BMJ · 219

PDF

Effects of dietary phytoestrogens in postmenopausal women

1998 · F. S. Dalais, G. E. Rice, et al. · Climacteric · 218

Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study

2017 · Jie-Bin Lew, D James B St John, et al. · The Lancet Public Health · 195

PDF

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program

2017 · Jie-Bin Lew, Kate T Simms, et al. · The Lancet Public Health · 171

PDF

Safety of Human Papillomavirus Vaccines: A Review

2013 · Kristine K. Macartney, Clayton Chiu, et al. · Drug Safety · 153

Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination

2018 · Dorothy A Machalek, Suzanne M Garland, et al. · The Journal of Infectious Diseases · 151

PDF

Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach

2013 · Julia M L Brotherton, Sharron L Murray, et al. · The Medical Journal of Australia · 148

Safety of Human Papillomavirus Vaccines: An Updated Review

2017 · Anastasia Phillips, Cyra Patel, et al. · Drug Safety · 145

HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity # †

2009 · Lyle C. Gurrin, Nadine A. Bertalli, et al. · Hepatology · 131

Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis

2019 · Julia ML. Brotherton, Alison Budd, et al. · Papillomavirus Research · 125

PDF

Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit

1995 · H Mitchell, G Medley, et al. · British Journal of Cancer · 124

PDF

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study

2017 · Nicholas M. Douglas, Jeanne Rini Poespoprodjo, et al. · PLoS Medicine · 121

PDF

Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis

2007 · Susan J. Jordan, Adèle C. Green, et al. · International Journal of Cancer · 118

PDF

Works count: 380

Citation count: 27,760